Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Keller

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Pediatric Hematology/Oncology|November 1, 1994
Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndromeF G Keller, J Kurtzberg
Journal of Pediatric Hematology/Oncology|August 14, 1998
An unusual histiocytic disorder responding to cyclosporine therapy: a case reportP R Ogershok, F G Keller, B E Favara, et al.
Biochemistry|March 28, 1995
Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.
The Journal of Pediatrics|February 21, 1998
The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous cathetersF G Keller, J DeFazio, F Jencks, et al.
Medical and Pediatric Oncology|January 1, 1996
Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's diseaseS S Winter, T A Howard, A K Ritchey, et al.
The West Virginia Medical Journal|July 1, 1997
Curing children with leukemia in West VirginiaA K Ritchey, K A Starling, F G Keller, et al.
The West Virginia Medical Journal|November 6, 1998
A survey of pediatric malignancy in West VirginiaF G Keller, K A Starling, J Martin, et al.
The Journal of Biological Chemistry|June 3, 1994
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.
American Journal of Hematology|February 1, 1994
Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosisT L Ortel, L A Charles, F G Keller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Pediatric Hematology/Oncology|November 1, 1994
Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndromeF G Keller, J Kurtzberg
Journal of Pediatric Hematology/Oncology|August 14, 1998
An unusual histiocytic disorder responding to cyclosporine therapy: a case reportP R Ogershok, F G Keller, B E Favara, et al.
Biochemistry|March 28, 1995
Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.
The Journal of Pediatrics|February 21, 1998
The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous cathetersF G Keller, J DeFazio, F Jencks, et al.
Medical and Pediatric Oncology|January 1, 1996
Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's diseaseS S Winter, T A Howard, A K Ritchey, et al.
The West Virginia Medical Journal|July 1, 1997
Curing children with leukemia in West VirginiaA K Ritchey, K A Starling, F G Keller, et al.
The West Virginia Medical Journal|November 6, 1998
A survey of pediatric malignancy in West VirginiaF G Keller, K A Starling, J Martin, et al.
The Journal of Biological Chemistry|June 3, 1994
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.
American Journal of Hematology|February 1, 1994
Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosisT L Ortel, L A Charles, F G Keller, et al.
Pageof 1